<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-TWG1A7GD/18f0cc85-dafa-4b5d-ae6b-264b7283c463/HTML"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-TWG1A7GD/55cb69f3-c2ea-4718-bc6b-c9c6b3d51527/PDF"><dcterms:extent>70 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-TWG1A7GD/401e8695-cacd-4393-97c1-d2ace40793b8/TEXT"><dcterms:extent>18 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-TWG1A7GD"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2009</dcterms:issued><dc:creator>Botros, Maikel</dc:creator><dc:creator>Miller, Robert C.</dc:creator><dc:creator>Quevedo, J. Fernando</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:43</dc:format><dc:format xml:lang="sl">str. 126-131</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:25672921</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-TWG1A7GD</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">Adverse Effects</dc:subject><dc:subject xml:lang="sl">angiosarkom</dc:subject><dc:subject xml:lang="en">Combined Modality Therapy</dc:subject><dc:subject xml:lang="en">Gallbladder Neoplasms</dc:subject><dc:subject xml:lang="sl">Hemangiosarcoma</dc:subject><dc:subject xml:lang="en">Hemangiosarkom</dc:subject><dc:subject xml:lang="sl">Jetra, novotvorbe</dc:subject><dc:subject xml:lang="sl">Kombinirani način zdravljenja</dc:subject><dc:subject xml:lang="en">Liver Neoplasms</dc:subject><dc:subject xml:lang="en">Middle Age</dc:subject><dc:subject xml:lang="sl">radioterapija</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">Srednja leta</dc:subject><dc:subject xml:lang="en">Therapy</dc:subject><dc:subject xml:lang="sl">žolčnik</dc:subject><dc:subject xml:lang="sl">Žolčnik, novotvorbe</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Angiosarcoma of the liver after multimodality therapy for gallbladder carcinoma|</dc:title><dc:description xml:lang="sl">Background. Treatment-induced angiosarcoma is a rare complication of cancer therapy and is best known for arising on the chest wall after a mastectomy. Wereport an unusual case of a treatment-induced angiosarcoma developing in theliver after adjuvant radiotherapy for gallbladder carcinoma. Case report. Radiation-induced angiosarcoma of the liver developed in a 46-year-old woman after radiotherapy for stage IIB (T3N1M0) adenocarcinoma of the gallbladder in1991. The patient subsequently underwent resection, postoperative external beam radiotherapy, and multiagent chemotherapy. Several severe late adverse effects developed, including duodenal obstruction with fistula formation and chronic mesenteric ischemia secondary to occlusion of the superior mesenteric artery. Six years after her gallbladder resection and adjuvant treatment, a fatal grade 4 of 4 angiosarcoma of the liver developed within the radiation field. Conclusions. To our knowledge, this is the first case of radiation-induced angiosarcoma of the liver after radiotherapy for gallbladdercarcinoma. Normal organ dose-volume limits should be considered carefully when delivering a course of external beam radiotherapy in the upper abdomen</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-TWG1A7GD"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-TWG1A7GD" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-TWG1A7GD/55cb69f3-c2ea-4718-bc6b-c9c6b3d51527/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-TWG1A7GD/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-TWG1A7GD" /></ore:Aggregation></rdf:RDF>